CHARLOTTE, N.C., Sept. 23, 2019 /PRNewswire-PRWeb/ -- MedShift today announced a new strategic partnership with Apyx Medical, a recognized manufacturer in surgical devices. The firms will work collaboratively to increase distribution volume and elevate brand awareness of Renvuion® Cosmetic Technology. Distribution of the manufacturer's devices across MedShift's extensive provider network will rapidly optimize business operations while diversifying MedShift's device portfolio.
"MedShift is thrilled to lend support advancing Renuvion® in market in the upcoming year," says MedShift CEO Brian Phillips. "As two innovation driven companies, providing game changing energy-based solutions for our clients is top of mind for both of us. We have every reason to anticipate successful assimilation of Renvuion® into our web of practices across the US."
Renvuion® touts vast applicability in minimally-invasive procedures. The device can be used to treat tissue on a variety of sites with a dual thermal effect facilitated by helium plasma. Thus it is uniquely able to provide controlled heat with a high level of precision to achieve desired results. Numerous surgical and cosmetic procedures have demonstrated its efficacy and safety.
Apyx Medical is an advanced cosmetic and surgical technology company founded in 1982. The company leverages decades of expertise in unique waveforms to manufacture original medical equipment. "Given Apyx and MedShift's shared commitment to delivering superior devices with unparalleled results to practitioners, I think this is a perfect time to join forces," adds Apyx Medical Executive Vice President Todd Hornsby. "This partnership supports our strategy to go above and beyond for providers and their patients."
Renvuion® will be integrated into MedShift's Tightening for Everything (T4E) brand, MedShift's fastest growing business sector which highlights medical aesthetic solutions. The medical technology company successfully added Emsculpt, Ultherapy® and Cellfina® devices to its T4E offerings earlier this year.
T4E's market acceptance and exceptional performance since its launch matches favorable economic conditions in the medical device industry. The US remains the world's largest medical device market, estimated at over $150 Billion as of 2019 and the global medical technology market is forecasted to continue expanding at a healthy 4.5% per year.
SOURCE MedShift
Advertisement
"MedShift is thrilled to lend support advancing Renuvion® in market in the upcoming year," says MedShift CEO Brian Phillips. "As two innovation driven companies, providing game changing energy-based solutions for our clients is top of mind for both of us. We have every reason to anticipate successful assimilation of Renvuion® into our web of practices across the US."
Advertisement
Renvuion® touts vast applicability in minimally-invasive procedures. The device can be used to treat tissue on a variety of sites with a dual thermal effect facilitated by helium plasma. Thus it is uniquely able to provide controlled heat with a high level of precision to achieve desired results. Numerous surgical and cosmetic procedures have demonstrated its efficacy and safety.
Apyx Medical is an advanced cosmetic and surgical technology company founded in 1982. The company leverages decades of expertise in unique waveforms to manufacture original medical equipment. "Given Apyx and MedShift's shared commitment to delivering superior devices with unparalleled results to practitioners, I think this is a perfect time to join forces," adds Apyx Medical Executive Vice President Todd Hornsby. "This partnership supports our strategy to go above and beyond for providers and their patients."
Renvuion® will be integrated into MedShift's Tightening for Everything (T4E) brand, MedShift's fastest growing business sector which highlights medical aesthetic solutions. The medical technology company successfully added Emsculpt, Ultherapy® and Cellfina® devices to its T4E offerings earlier this year.
T4E's market acceptance and exceptional performance since its launch matches favorable economic conditions in the medical device industry. The US remains the world's largest medical device market, estimated at over $150 Billion as of 2019 and the global medical technology market is forecasted to continue expanding at a healthy 4.5% per year.
SOURCE MedShift
